Skip to main content
. 2019 May 4;28(1):33–37. doi: 10.1136/ejhpharm-2019-001870

Table 3.

Comparison of patient groups according to secondary criteria for analysis

Criteria Total Urinary Recombinant Combined P values
Mean FSH dose per cycle* 1818.5 (1050–2700) 2025 (1050–2850) 1575 (1050–2000) 1875 (1050–2700) <0.0001
COH duration (days)† 10 (9-11) 10 (9-11) 10 (9-11) 11 (10-12) <0.0001
LH levels on the day of hCG 2.10 (1.24–3.62) 2.20 (1.35–3.8) 1.87 (1.14–3.07) 1.94 (1.08–3.33) <0.001
Progesterone levels on the day of hCG 0.93 (0.63–1.40) 0.94 (0.65–1.42) 1.06 (0.79–1.5) 0.85 (0.54–1.25) <0.001
Oocyte yield 5 (3-9) 5 (2-9) 8 (5-11) 5 (3-9) <0.0001
Oocytes with normal maturation* 4 (2-7) 3 (1-6) 5 (3-8) 3 (2-6) <0.0001
Age 37 (32–40) 37 (33–41) 29 (33–37) 36 (32–40) <0.0001

*only patients with their own oocytes.

†only patients who have reached puncture.